Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism

被引：0
|
作者：
Bo Xie
Ying Qiu
Juan Zhou
Dou Du
Haochuan Ma
Jiapeng Ji
Liquan Zhu
Weimin Zhang
机构：
[1] General Hospital of Southern Theater Command,Department of Oncology
[2] PLA,undefined
来源：
Clinical and Translational Oncology | 2022年 / 24卷
关键词：
Lorlatinib resistance; Non-small cell lung cancer; -; Mechanism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2231 / 2240
页数：9
相关论文
共 50 条
  • [21] Acquired nintedanib resistance in FGFR1-driven small cell but not non-small cell lung cancer is mediated by ABCB1
    Englinger, Bernhard
    Lotsch, Daniela
    Pirker, Christine
    van Schoonhoven, Sushilla
    Boidol, Bernd
    Lardeau, Charles
    Kubicek, Stefan
    Szabo, Pal
    Szakacs, Gergely
    Berger, Walter
    CANCER RESEARCH, 2016, 76
  • [22] Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
    Rath, Barbara
    Plangger, Adelina
    Hamilton, Gerhard
    CANCER DRUG RESISTANCE, 2020, 3 (02) : 171 - 178
  • [23] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [24] Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
    Memon, Danish
    Schoenfeld, Adam J.
    Ye, Darwin
    Fromm, George
    Rizvi, Hira
    Zhang, Xiang
    Keddar, Mohamed Reda
    Mathew, Divij
    Yoo, Kyung Jin
    Qiu, Jingya
    Lihm, Jayon
    Miriyala, Jayalaksmi
    Sauter, Jennifer L.
    Luo, Jia
    Chow, Andrew
    Bhanot, Umesh K.
    Mccarthy, Caroline
    Vanderbilt, Chad M.
    Liu, Cailian
    Abu-Akeel, Mohsen
    Plodkowski, Andrew J.
    Mcgranahan, Nicholas
    Quksza, Marta
    Greenbaum, Benjamin D.
    Merghoub, Taha
    Achour, Ikbel
    Barrett, J. Carl
    Stewart, Ross
    Beltrao, Pedro
    Schreiber, Taylor H.
    Minn, Andy J.
    Miller, Martin L.
    Hellmann, Matthew D.
    CANCER CELL, 2024, 42 (02) : 209 - 224.e9
  • [25] Survival versus intrinsic and acquired resistance in advanced non-small cell lung cancer
    Stewart, David J.
    Saintigny, Pierre
    Goss, Glenwood D.
    Lu, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] CLINICAL AND MOLECULAR FEATURES OF ACQUIRED RESISTANCE TO IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Memon, Danish
    Hellmann, Matthew
    Miller, Martin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A548 - A548
  • [27] Establishment and characterization of human non-small cell lung cancer cell lines
    Li, Jiangchao
    Yang, Hong
    Chen, Leilei
    Li, Yan
    Zhu, Yinghui
    Dai, Yongdong
    Chen, Kai
    Ai, Jiaoyu
    Zeng, Tingting
    Mao, Xueying
    Liu, Lulu
    Li, Xiaodong
    Guan, Xin-Yuan
    MOLECULAR MEDICINE REPORTS, 2012, 5 (01) : 114 - 117
  • [28] Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management
    Basse, Clemence
    Swalduz, Aurelie
    Giaj Levra, Matteo
    Girard, Nicolas
    Remon, Jordi
    Moro-Sibilot, Denis
    BULLETIN DU CANCER, 2020, 107 (7-8) : 779 - 791
  • [29] Photodynamic therapy in non-small cell lung cancer cell line
    Laranjo, M.
    Santos, K.
    Teixo, R.
    Pineiro, M.
    Goncalves, A. C.
    Abrantes, A. M.
    Sarmento-Ribeiro, A. B.
    Rocha-Gonsalves, A. M.
    Serra, A. C.
    Botelho, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S196 - S196
  • [30] Drug resistance in non-small cell lung cancer
    Monzo, M
    Rosell, R
    Taron, M
    LUNG CANCER, 2001, 34 : S91 - S94
12345